Search research articles
Contact Us
Filters
Showing results (61-70 of 181) with videos related to
Page
of 19
Sort By:
Radiology
|
February 1, 1973
Vascular imaging with 99m Tc-red blood cells
H L Atkins, W C Eckelman, J F Klopper, et al.
Bioorganic & Medicinal Chemistry
|
December 5, 1998
Synthesis and screening of conformationally restricted and conformationally free N-(tertiary aminoalkyl)dithiocarbamic acids and esters as inhibitors of neuronal nitric oxide synthase
M B Sassaman, J Giovanelli, V K Sood, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 1, 1974
Clinical evaluation of radiolabeled bleomycin (BLEO) for tumor detection
R B Grove, R C Reba, W C Eckelman, et al.
Journal of Pharmaceutical Sciences
|
May 1, 1993
A multi-organ, axially distributed model of capillary permeability for a magnetic resonance imaging contrast agent
S M Eaton, P Wedeking, M F Tweedle, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
January 1, 1996
Synthesis of polymer-bound 6-mercuric carboxylate DOPA precursors and solid phase labelling method of 6-radioiodinated L-DOPA
K Kawai, H Ohta, M A Channing, et al.
Annals of the New York Academy of Sciences
|
February 3, 1999
VIP and breast cancer
T W Moody, J Leyton, I Gozes, et al.
Nuclear Medicine and Biology
|
April 1, 1996
Synthesis and evaluation of radioiodinated 6-iodo-L-DOPA as a cerebral L-amino acid transport marker
K Kawai, H Ohta, A Kubodera, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 1, 1971
Technetium-labeled red blood cells
M B Weinstein, W C Eckelman, P Richards, et al.
Journal of Medicinal Chemistry
|
June 1, 1979
Cardioselectivity of beta-adrenoceptor blocking agents 1. 1-[(4-Hydroxyphenethyl)amino]-3-(aryloxy)propan-2-ols
W J Rzeszotarski, R E Gibson, W C Eckelman, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 8, 2005
Why does the agonist [(18)F]FP-TZTP bind preferentially to the M(2) muscarinic receptor?
L Ravasi, D O Kiesewetter, K Shimoji, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 181) with videos related to
Sort By:
Page
of 19
Radiology
|
February 1, 1973
Vascular imaging with 99m Tc-red blood cells
H L Atkins, W C Eckelman, J F Klopper, et al.
Bioorganic & Medicinal Chemistry
|
December 5, 1998
Synthesis and screening of conformationally restricted and conformationally free N-(tertiary aminoalkyl)dithiocarbamic acids and esters as inhibitors of neuronal nitric oxide synthase
M B Sassaman, J Giovanelli, V K Sood, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 1, 1974
Clinical evaluation of radiolabeled bleomycin (BLEO) for tumor detection
R B Grove, R C Reba, W C Eckelman, et al.
Journal of Pharmaceutical Sciences
|
May 1, 1993
A multi-organ, axially distributed model of capillary permeability for a magnetic resonance imaging contrast agent
S M Eaton, P Wedeking, M F Tweedle, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
January 1, 1996
Synthesis of polymer-bound 6-mercuric carboxylate DOPA precursors and solid phase labelling method of 6-radioiodinated L-DOPA
K Kawai, H Ohta, M A Channing, et al.
Annals of the New York Academy of Sciences
|
February 3, 1999
VIP and breast cancer
T W Moody, J Leyton, I Gozes, et al.
Nuclear Medicine and Biology
|
April 1, 1996
Synthesis and evaluation of radioiodinated 6-iodo-L-DOPA as a cerebral L-amino acid transport marker
K Kawai, H Ohta, A Kubodera, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 1, 1971
Technetium-labeled red blood cells
M B Weinstein, W C Eckelman, P Richards, et al.
Journal of Medicinal Chemistry
|
June 1, 1979
Cardioselectivity of beta-adrenoceptor blocking agents 1. 1-[(4-Hydroxyphenethyl)amino]-3-(aryloxy)propan-2-ols
W J Rzeszotarski, R E Gibson, W C Eckelman, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 8, 2005
Why does the agonist [(18)F]FP-TZTP bind preferentially to the M(2) muscarinic receptor?
L Ravasi, D O Kiesewetter, K Shimoji, et al.
Page
of 19